Bavarian Nordic (OTCMKTS:BVNRY – Get Free Report) passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $8.35 and traded as high as $9.03. Bavarian Nordic shares last traded at $8.92, with a volume of 1,173 shares changing hands.
Bavarian Nordic Stock Performance
The business’s fifty day moving average is $8.35 and its 200-day moving average is $8.35. The firm has a market cap of $2.11 billion, a P/E ratio of 11.16 and a beta of 1.36.
Bavarian Nordic (OTCMKTS:BVNRY – Get Free Report) last announced its quarterly earnings data on Friday, May 9th. The company reported $0.13 EPS for the quarter. The company had revenue of $189.89 million during the quarter. Bavarian Nordic had a net margin of 21.11% and a return on equity of 11.89%. Analysts predict that Bavarian Nordic will post 0.67 EPS for the current fiscal year.
Bavarian Nordic Company Profile
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.
See Also
- Five stocks we like better than Bavarian Nordic
- Stock Splits, Do They Really Impact Investors?
- New All-Time Highs Coming for Broadcom? Wall Street Says Yes
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Overheated Market? Analysts Watch These Red Flags
- Golden Cross Stocks: Pattern, Examples and Charts
- 3 Reasons AMD Could Be the Hottest Stock of the Summer
Receive News & Ratings for Bavarian Nordic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bavarian Nordic and related companies with MarketBeat.com's FREE daily email newsletter.
